• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYT
Click for more information
0.00% 13.0¢

CYTOPIA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
CYTSuspension from Official QuotationPRICE SENSITIVE18/01/10
CYTDosing in Cytopia's CYT387 clinical trial beginsPRICE SENSITIVE24/11/09
CYTUpdate on Merger with YM BioSciencesPRICE SENSITIVE02/11/09
CYTCytopia opens fourth clinical centre for CYT997 glioma studyPRICE SENSITIVE19/10/09
CYTCytopia merger with YM BioSciences IncPRICE SENSITIVE06/10/09
CYTCytopia achieves grant of further patent for JAK2 programPRICE SENSITIVE30/09/09
CYTCYT387 receives FDA clearance to start US clinical trialsPRICE SENSITIVE04/09/09
CYTPreliminary Final ReportPRICE SENSITIVE25/08/09
CYTCytopia lodges IND for JAK2 inhibitor CYT387PRICE SENSITIVE23/06/09
CYTCytopia secures key patentsPRICE SENSITIVE16/06/09
CYTCytopia Moves Focus to Clinical Stage Cancer CompanyPRICE SENSITIVE05/06/09
CYTCancer Program Reaches Important MilestonePRICE SENSITIVE26/05/09
CYTProtein structure involved in immune system/cancer solvedPRICE SENSITIVE24/03/09
CYTHalf Yearly Report and AccountsPRICE SENSITIVE09/02/09
CYTCytopia Concludes Phase I Oral Trial for CYT997PRICE SENSITIVE05/02/09
CYTSuspension from Official Quotation
18/01/10PRICE SENSITIVE
CYTDosing in Cytopia's CYT387 clinical trial begins
24/11/09PRICE SENSITIVE
CYTUpdate on Merger with YM BioSciences
02/11/09PRICE SENSITIVE
CYTCytopia opens fourth clinical centre for CYT997 glioma study
19/10/09PRICE SENSITIVE
CYTCytopia merger with YM BioSciences Inc
06/10/09PRICE SENSITIVE
CYTCytopia achieves grant of further patent for JAK2 program
30/09/09PRICE SENSITIVE
CYTCYT387 receives FDA clearance to start US clinical trials
04/09/09PRICE SENSITIVE
CYTPreliminary Final Report
25/08/09PRICE SENSITIVE
CYTCytopia lodges IND for JAK2 inhibitor CYT387
23/06/09PRICE SENSITIVE
CYTCytopia secures key patents
16/06/09PRICE SENSITIVE
CYTCytopia Moves Focus to Clinical Stage Cancer Company
05/06/09PRICE SENSITIVE
CYTCancer Program Reaches Important Milestone
26/05/09PRICE SENSITIVE
CYTProtein structure involved in immune system/cancer solved
24/03/09PRICE SENSITIVE
CYTHalf Yearly Report and Accounts
09/02/09PRICE SENSITIVE
CYTCytopia Concludes Phase I Oral Trial for CYT997
05/02/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
ASX Market Open: Aussie investors to power past concerns raised by Trump's tariff threats | November 27, 2024 The ASX 200, much like Wall Street overnight, is expected to power through newly flared-up Trump tariff concerns to lift today with the market already up 0.41% in futures.U.S. markets shrugged off the President-elect’s pledge to impose major tariffs on the country’...
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.